Published • loading... • Updated
First patients enrolled in study of pulsatile IVL in coronary artery disease
Summary by Cardiovascular News
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
First patients enrolled in study of pulsatile IVL in coronary artery disease
Amplitude Vascular Systems (AVS), a medical device company recently acquired by Stryker, has announced the enrolment of the first patient in its first-in-human (FIH) study for pulsatile intravascular lithotripsy (PIVL) therapy in a coronary indication. The POWER CAD I study will evaluate the feasibility of the Pulse IVL system for the treatment of patients with moderate to severely calcified coronary arterial disease. Jithendra Somaratne, interv…
Father's Day SaleGet 40% off Vantage subscriptions for yourself or a friend.Get Started
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
